Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. Long Term Debt 2023–2025
Inhibrx Biosciences, Inc. annual/quarterly long term debt history from 2023 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Inhibrx Biosciences, Inc. long term debt for the quarter ending December 31, 2025 were 100.6M, a 51.41% decrease year-over-year.
- Inhibrx Biosciences, Inc. long term debt for 2025 were 100.6M, a 51.41% decrease from 2023.
- Inhibrx Biosciences, Inc. long term debt for 2023 were 207.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Inhibrx Biosciences, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $101 |
| 2023 | $207 |
| Inhibrx Biosciences, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $101 |
| 2023-12-31 | $207 |
Inhibrx Biosciences, Inc. Long Term Debt — FAQ
Inhibrx Biosciences, Inc. (INBX) long term debt over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INBX's long term debt history?
The chart and table above show Inhibrx Biosciences, Inc.'s long term debt by year and by quarter, including the growth rate.